Sectra promises "future-proof" PACS with next-gen system
This article was originally published in Clinica
Executive Summary
Swedish picture archiving and communications systems (PACS) supplier Sectra has announced the launch of the third phase of the deployment of its next-generation system. The PACS 12.1 features patent-pending RapidConnect technology that promises to provide better performance in large-stack reading, together with new integrated solutions, including 3D capabilities and "full web-based deployment". The 12.1 release was described by radiology IT vice-president Staffan Bergström as "future-proof". Northern Ireland's health service has become one of the first to install the new system and will use it to perform more than 1 million examinations per year, said the Linköping-based firm.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.